Introducing
National Institute of Biotechnology Malaysia POSTGRADUATE STUDIES
POSTGRADUATE STUDIES
The Malaysian Institute of Pharmaceuticals and Nutraceuticals (IPharm) was initiated by the Ministry of Science, Technology & Innovation (MOSTI) under the directive of the BIOTEK Division in 2006. In collaboration with Universiti Sains Malaysia (USM), it offers Master and Doctoral degree programmes in various facets of health and pharmaceutical research. Capable academicians who have considerable expertise in conducting research will supervise students following the various postgraduate degree programmes.
As the institute is affiliated to MOSTI, undertaken research programmes and topics will be closely related to relevant issues such as the National Biotechnology Policy, an important component of Vision 2020 to establish a knowledge-based economy in Malaysia. Therefore, this joint effort of IPharm and USM postgraduate programme will enable initiation of research projects relevant to the Government’s agenda, which will bridge the existing gap between academia and policy makers while maintaining the high quality of USM’s postgraduate program.
IPharm aims at developing new pharmaceuticals and nutraceuticals with commercial potential by focusing on the following:
Identifying niche areas in pharmaceutical and nutraceutical biotechnology by exploiting readily available natural resources in Malaysia. Ensuring regulatory complaint in its pharmaceutical and nutraceutical biotechnology R&D. Sustaining prioritized R&D activities and adapting to the latest technology in the research of drug discovery and development.

POSTGRADUATE STUDIES
Programme
We offer postgraduate programme by research in Healthcare Biotechnology in line with IPharm objectives that aims to develop new pharmaceuticals and nutraceuticals with commercialisation potential.
Research Area:Healthcare Biotechnology, Molecular Medicine, Rapid Diagnostics, Vaccinology, Tissue Engineering, Biomaterial Science, Pharmacogenetics, Novel Therapy, Mechanisms of Disease, Cancer Research, RNA Technology

POSTGRADUATE STUDIES
Study Duration
MSc
Full-time: Min 2 semesters / Max 6 semesters | Part-time: Min 4 semesters / Max 12 semesters
PhD
Full-time: Min 4 semesters / Max 10 semesters | Part-time: Min 6 semesters / Max 15 semesters
POSTGRADUATE STUDIES
Admission Requirement
Doctor of Philosophy-PhD
a Master’s or Bachelor’s (First Class Honours or CGPA>3.67/4) degree in a related area. OR a Master’s degree (non-research mode) with a minimum CGPA of 3.00/4 or equivalent.
Language Requirement (Applicable for International Applicants Only)*
* a minimum score of 550 (Paper-based) in TOEFL (Test of English as a Foreign Language); OR a minimum score of 213 (Computer-based) in TOEFL (Test of English as a Foreign Language); or A minimum score of 80 (Internet-based) in TOEFL (Test of English as a Foreign Language); OR a minimum score of 6.0 in IELTS (International English Language Testing System).
Master of Science (Healthcare Biotechnology)-MSc
a degree in Pharmacy, Pharmaceutical Sciences, Chemistry (Pure or Applied), Microbiology, Biotechnology (with a minimum CGPA of 3.00/4 or equivalent (International students) AND a minimum CGPA of 2.75/4 for Malaysian with Pharmacy degree; OR a Bachelor’s degree in a related area with minimum CGPA stated above. Language Requirement (Applicable for International Applicants Only)*
* a minimum score of 550 (Paper-based) in TOEFL (Test of English as a Foreign Language); OR a minimum score of 213 (Computer-based) in TOEFL (Test of English as a Foreign Language); OR a minimum score of 80 (Internet-based) in TOEFL (Test of English as a Foreign Language); OR a minimum score of 6.0 in IELTS (International English Language Testing System).